Showing results (61-70 of 106) with videos related to
Sort By:
Pageof 11
Autophagy|June 2, 2015
The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMMLSandrine Obba, Zoheir Hizir, Laurent Boyer, et al.Cell Reports. Medicine|November 18, 2020
CD103<sup>+</sup>CD8<sup>+</sup> T<sub>RM</sub> Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17Stéphanie Corgnac, Ines Malenica, Laura Mezquita, et al.Blood|October 10, 2015
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patientsXénia Cabagnols, Fabrizia Favale, Florence Pasquier, et al.The EMBO Journal|September 17, 2021
DNA polymerase zeta contributes to heterochromatin replication to prevent genome instabilityBarbara Ben Yamin, Sana Ahmed-Seghir, Junya Tomida, et al.Blood|July 8, 2011
Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitorsElodie Pronier, Carole Almire, Hayat Mokrani, et al.Nature Communications|November 28, 2017
Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defectKahia Messaoudi, Ashfaq Ali, Rameez Ishaq, et al.Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.Leukemia|March 22, 2019
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemiaNolwenn Lucas, Matthieu Duchmann, Philippe Rameau, et al.Haematologica|February 16, 2023
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesisFrancesca Basso-Valentina, Alessandro Donada, Vladimir T Manchev, et al.Pageof 11